Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Implication of Hepsin from Primary Tumor in the Prognosis of Colorectal Cancer Patients.
Cancers (Basel). 2022 Jun 24;14(13):3106. doi: 10.3390/cancers14133106.
Cancers (Basel). 2022.
PMID: 35804878
Free PMC article.
Anti-Tumor Functions of Prelatent Antithrombin on Glioblastoma Multiforme Cells.
Peñas-Martínez J, Luengo-Gil G, Espín S, Bohdan N, Ortega-Sabater C, Ródenas MC, Zaragoza-Huesca D, López-Andreo MJ, Plasencia C, Vicente V, Carmona-Bayonas A, Martínez-Martínez I.
Peñas-Martínez J, et al. Among authors: zaragoza huesca d.
Biomedicines. 2021 May 7;9(5):523. doi: 10.3390/biomedicines9050523.
Biomedicines. 2021.
PMID: 34067120
Free PMC article.
Item in Clipboard
Identification of Thrombosis-Related Genes in Patients with Advanced Gastric Cancer: Data from AGAMENON-SEOM Registry.
Zaragoza-Huesca D, Garrido-Rodríguez P, Jiménez-Fonseca P, Martínez de Castro E, Sánchez-Cánovas M, Visa L, Custodio A, Fernández-Montes A, Peñas-Martínez J, Morales Del Burgo P, Gallego J, Luengo-Gil G, Vicente V, Martínez-Martínez I, Carmona-Bayonas A.
Zaragoza-Huesca D, et al.
Biomedicines. 2022 Jan 11;10(1):148. doi: 10.3390/biomedicines10010148.
Biomedicines. 2022.
PMID: 35052827
Free PMC article.
Item in Clipboard
Identification of Kukoamine A, Zeaxanthin, and Clexane as New Furin Inhibitors.
Zaragoza-Huesca D, Martínez-Cortés C, Banegas-Luna AJ, Pérez-Garrido A, Vegara-Meseguer JM, Peñas-Martínez J, Rodenas MC, Espín S, Pérez-Sánchez H, Martínez-Martínez I.
Zaragoza-Huesca D, et al.
Int J Mol Sci. 2022 Mar 3;23(5):2796. doi: 10.3390/ijms23052796.
Int J Mol Sci. 2022.
PMID: 35269938
Free PMC article.
Item in Clipboard
Suramin, a drug for the treatment of trypanosomiasis, reduces the prothrombotic and metastatic phenotypes of colorectal cancer cells by inhibiting hepsin.
Zaragoza-Huesca D, Rodenas MC, Peñas-Martínez J, Pardo-Sánchez I, Peña-García J, Espín S, Ricote G, Nieto A, García-Molina F, Vicente V, Lozano ML, Carmona-Bayonas A, Mulero V, Pérez-Sánchez H, Martínez-Martínez I.
Zaragoza-Huesca D, et al.
Biomed Pharmacother. 2023 Dec;168:115814. doi: 10.1016/j.biopha.2023.115814. Epub 2023 Oct 31.
Biomed Pharmacother. 2023.
PMID: 37918256
Free article.
Item in Clipboard
Venetoclax is a potent hepsin inhibitor that reduces the metastatic and prothrombotic phenotypes of hepsin-expressing colorectal cancer cells.
Rodenas MC, Peñas-Martínez J, Pardo-Sánchez I, Zaragoza-Huesca D, Ortega-Sabater C, Peña-García J, Espín S, Ricote G, Montenegro S, Ayala-De La Peña F, Luengo-Gil G, Nieto A, García-Molina F, Vicente V, Bernardi F, Lozano ML, Mulero V, Pérez-Sánchez H, Carmona-Bayonas A, Martínez-Martínez I.
Rodenas MC, et al. Among authors: zaragoza huesca d.
Front Mol Biosci. 2023 May 19;10:1182925. doi: 10.3389/fmolb.2023.1182925. eCollection 2023.
Front Mol Biosci. 2023.
PMID: 37275957
Free PMC article.
Item in Clipboard
Cite
Cite